Free Trial

Medical Properties Trust, Inc. (NYSE:MPW) Receives Average Rating of "Hold" from Brokerages

Medical Properties Trust logo with Finance background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Shares of Medical Properties Trust, Inc. (NYSE:MPW - Get Free Report) have received a consensus rating of "Hold" from the eight analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $5.6667.

A number of equities research analysts have issued reports on the company. Royal Bank Of Canada lowered their price target on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a research report on Monday, June 30th. Zacks Research raised Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research report on Wednesday. Finally, Wall Street Zen downgraded Medical Properties Trust from a "hold" rating to a "sell" rating in a research report on Saturday, July 5th.

View Our Latest Stock Report on Medical Properties Trust

Institutional Investors Weigh In On Medical Properties Trust

Several institutional investors and hedge funds have recently modified their holdings of the stock. Charles Schwab Investment Management Inc. boosted its position in shares of Medical Properties Trust by 13.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock worth $60,424,000 after buying an additional 1,182,028 shares during the period. Allianz Asset Management GmbH boosted its position in shares of Medical Properties Trust by 43.2% in the first quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock worth $43,022,000 after buying an additional 2,152,861 shares during the period. Northern Trust Corp boosted its position in shares of Medical Properties Trust by 1.5% in the first quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust's stock worth $38,620,000 after buying an additional 95,525 shares during the period. Wilsey Asset Management Inc. lifted its stake in shares of Medical Properties Trust by 6.1% in the second quarter. Wilsey Asset Management Inc. now owns 4,927,568 shares of the real estate investment trust's stock worth $21,238,000 after acquiring an additional 281,591 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Medical Properties Trust by 11.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust's stock valued at $24,644,000 after purchasing an additional 410,374 shares during the last quarter. Hedge funds and other institutional investors own 71.79% of the company's stock.

Medical Properties Trust Trading Down 0.6%

Medical Properties Trust stock traded down $0.0250 during trading on Tuesday, hitting $4.3050. The company's stock had a trading volume of 9,068,446 shares, compared to its average volume of 8,800,078. The stock has a market capitalization of $2.59 billion, a price-to-earnings ratio of -1.80 and a beta of 1.28. The stock's fifty day moving average is $4.25 and its 200 day moving average is $4.89. Medical Properties Trust has a 1-year low of $3.51 and a 1-year high of $6.55. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.76 and a current ratio of 2.76.

Medical Properties Trust (NYSE:MPW - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $240.36 million during the quarter, compared to analyst estimates of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The business's revenue for the quarter was down 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 earnings per share. As a group, equities research analysts predict that Medical Properties Trust will post 0.78 EPS for the current year.

Medical Properties Trust Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 9th. Shareholders of record on Thursday, September 11th will be given a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 7.4%. The ex-dividend date of this dividend is Thursday, September 11th. Medical Properties Trust's payout ratio is -13.39%.

About Medical Properties Trust

(Get Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Featured Stories

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines